Natera
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Natera and other ETFs, options, and stocks.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
CEOStephen Chapman
CEOStephen Chapman
Employees3,293
Employees3,293
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2003
Founded2003
Employees3,293
Employees3,293
NTRA Key Statistics
Market cap22.17B
Market cap22.17B
Price-Earnings ratio-94.64
Price-Earnings ratio-94.64
Dividend yield—
Dividend yield—
Average volume2.18M
Average volume2.18M
High today$169.80
High today$169.80
Low today$160.18
Low today$160.18
Open price$163.83
Open price$163.83
Volume2.03M
Volume2.03M
52 Week high$169.80
52 Week high$169.80
52 Week low$53.62
52 Week low$53.62
NTRA News
Simply Wall St 2d
Subdued Growth No Barrier To Natera, Inc. With Shares Advancing 25%Natera, Inc. ( ) shareholders have had their patience rewarded with a 25% share price jump in the last month. The annual gain comes to 180% following the latest...
Simply Wall St 6d
Natera, Inc. Released Earnings Last Week And Analysts Lifted Their Price Target To US$158Natera, Inc. ( ) just released its latest quarterly results and things are looking bullish. The results were impressive, with revenues of US$440m exceeding anal...
Simply Wall St 7d
Natera Third Quarter 2024 Earnings: Beats ExpectationsNatera ( ) Third Quarter 2024 Results Key Financial Results Revenue: US$439.8m (up 64% from 3Q 2023). Net loss: US$31.6m (loss narrowed by 71% from 3Q 2023)....
Analyst ratings
95%
of 20 ratingsBuy
95%
Hold
0%
Sell
5%